Page 82 - AN-3-3

Advanced Neurology mTOR inhibition in epilepsy

doi: 10.1002/ana.23943 in the amygdala stimulation model of temporal lobe epilepsy.
Neurosci Lett. 2012;509(2):105-109.
36. Sosanya NM, Brager DH, Wolfe S, Niere F, Raab-Graham KF.
Rapamycin reveals an mTOR-independent repression of doi: 10.1016/j.neulet.2011.12.051
Kv1.1 expression during epileptogenesis. Neurobiol Dis.
2015;73:96-105. 47. Talos DM, Sun H, Zhou X, et al. The interaction between
early life epilepsy and autistic-like behavioral consequences:
doi: 10.1016/j.nbd.2014.09.011 A role for the mammalian target of rapamycin (mTOR)
37. Hsieh LS, Wen JH, Nguyen LH, et al. Ectopic HCN4 pathway. PLoS One. 2012;7(5):e35885.
expression drives mTOR-dependent epilepsy in mice. Sci doi: 10.1371/journal.pone.0035885
Transl Med. 2020;12(570):eabc1492.
48. Guo D, Zeng L, Brody DL, Wong M. Rapamycin attenuates
doi: 10.1126/scitranslmed.abc1492 the development of posttraumatic epilepsy in a mouse model
38. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, of traumatic brain injury. PLoS One. 2013;8(5):e64078.
Sabatini BL. Regulation of neuronal morphology and doi: 10.1371/journal.pone.0064078
function by the tumor suppressors Tsc1 and Tsc2. Nat
Neurosci. 2005;8(12):1727-1734. 49. Hartman AL, Santos P, Dolce A, Hardwick JM. The mTOR
inhibitor rapamycin has limited acute anticonvulsant effects
doi: 10.1038/nn1566 in mice. PLoS One. 2012;7(9):e45156.
39. Cho CH. Frontier of epilepsy research-mTOR signaling doi: 10.1371/journal.pone.0045156
pathway. Exp Mol Med. 2011;43(5):231-274.
50. Huang X, McMahon J, Yang J, Shin D, Huang Y. Rapamycin
doi: 10.3858/emm.2011.43.5.032 down-regulates KCC2 expression and increases seizure
40. Nguyen LH, Bordey A. Convergent and divergent susceptibility to convulsants in immature rats. Neuroscience.
mechanisms of epileptogenesis in mTORopathies. Front 2012;219:33-47.
Neuroanat. 2021;15:664695. doi: 10.1016/j.neuroscience.2012.05.003

doi: 10.3389/fnana.2021.664695 51. U.S. Food and Drug Administration. Rapamune (Sirolimus)-
41. Meikle L, Pollizzi K, Egnor A, et al. Response of a neuronal Highlights of Prescribing Information. Silver Spring: U.S. Food
model of tuberous sclerosis to mammalian target of and Drug Administration; 2017. Available from: https://
rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt www.accessdata.fda.gov/drugsatfda_docs/label/2017/02108
signaling lead to improved survival and function. J Neurosci. 3s059,021110s076lb.pdf [Last accessed on 2023 Jan 19].
2008;28(21):5422-5432.
52. U.S. Food and Drug Administration. Everolimus (Zortress).
doi: 10.1523/JNEUROSCI.0955-08.2008 Silver Spring: U.S. Food and Drug Administration; 2010.
Available from: https://www.accessdata.fda.gov/drugsatfda_
42. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin docs/label/2010/021560s000lbl.pdf [Last accessed on
prevents epilepsy in a mouse model of tuberous sclerosis
complex. Ann Neurol. 2008;63(4):444-453. 2023 Jan 19].
53. U.S. Food and Drug Administration. Afinitor (Everolimus)
doi: 10.1002/ana.21331
Tablets for Oral Administration-Highlights of Prescribing
43. Ljungberg MC, Sunnen CN, Lugo JN, Anderson AE, Information. Silver Spring: U.S. Food and Drug Administration;
D’Arcangelo G. Rapamycin suppresses seizures and neuronal 2012. Available from: https://www.accessdata.fda.gov/
hypertrophy in a mouse model of cortical dysplasia. Dis drugsatfda_docs/label/2012/022334s016lbl.pdf [Last
Model Mech. 2009;2(7-8):389-398. accessed on 2023 Jan 19].
doi: 10.1242/dmm.002386 54. U.S. Food and Drug Administration. Everolimus (Afinitor/
44. Zeng LH, Rensing NR, Wong M. The mammalian target Afinitor Disperz). Silver Spring: U.S. Food and Drug
of rapamycin signaling pathway mediates epileptogenesis Administration; 2018. Available from: https://www.
in a model of temporal lobe epilepsy. J Neurosci. accessdata.fda.gov/drugsatfda_docs/label/2018/022334s040
2009;29(21):6964-6972. ,203985s013lbl.pdf [Last accessed on 2023 Jan 19].
doi: 10.1523/JNEUROSCI.0066-09.2009 55. U.S. Food and Drug Administration. Temsirolimus (Torisel
Kit) Injection, for Intravenous Infusion Only-Highlights of
45. Buckmaster PS, Lew FH. Rapamycin suppresses mossy fiber Prescribing Information. Silver Spring: U.S. Food and Drug
sprouting but not seizure frequency in a mouse model of Administration; 2021. Available from: https://www.accessdata.
temporal lobe epilepsy. J Neurosci. 2011;31(6):2337-2347. fda.gov/drugsatfda_docs/label/2018/022088s021s023lbl.pdf
doi: 10.1523/JNEUROSCI.4852-10.2011 [Last accessed on 2023 Jan 19].
46. Sliwa A, Plucinska G, Bednarczyk J, Lukasiuk K. Post- 56. Vézina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989),
treatment with rapamycin does not prevent epileptogenesis a new antifungal antibiotic. I. Taxonomy of the producing

Volume 3 Issue 3 (2024) 18 doi: 10.36922/an.3568